Bone Biologics Corp (BBLG) stock
BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)
Close on Nov 18, 2026Market cap $986.22KP/E –Yield –
Bone Biologics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Bone Biologics's total debt was $11.71M at Dec 31, 2020. For fiscal 2020 it was $11.71M, up 3.5% from the year before. The highest annual figure on record is $11.71M in fiscal 2020.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $11.71M | +3.5% |
| FY2019 | Dec 31, 2019 | $11.32M | +25.8% |
| FY2018 | Dec 31, 2018 | $9.00M | +9.4% |
| FY2017 | Dec 31, 2017 | $8.23M | +8.8% |
| FY2016 | Dec 31, 2016 | $7.56M | +48.8% |
| FY2015 | Dec 31, 2015 | $5.08M | +39.4% |
| FY2014 | Dec 31, 2014 | $3.65M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | $11.71M | +3.5% |
| Q3 FY2020 | Sep 30, 2020 | $11.60M | +3.6% |
| Q2 FY2020 | Jun 30, 2020 | $11.52M | +7.7% |
| Q1 FY2020 | Mar 31, 2020 | $11.45M | +18.0% |
| Q4 FY2019 | Dec 31, 2019 | $11.32M | +25.8% |
| Q3 FY2019 | Sep 30, 2019 | $11.20M | +24.4% |
| Q2 FY2019 | Jun 30, 2019 | $10.70M | +25.0% |
| Q1 FY2019 | Mar 31, 2019 | $9.70M | +15.5% |
| Q4 FY2018 | Dec 31, 2018 | $9.00M | +9.4% |
| Q3 FY2018 | Sep 30, 2018 | $9.00M | +12.1% |
| Q2 FY2018 | Jun 30, 2018 | $8.56M | +8.9% |
| Q1 FY2018 | Mar 31, 2018 | $8.40M | +8.6% |
| Q4 FY2017 | Dec 31, 2017 | $8.23M | +8.8% |
| Q3 FY2017 | Sep 30, 2017 | $8.03M | +8.5% |
| Q2 FY2017 | Jun 30, 2017 | $7.86M | – |
| Q1 FY2017 | Mar 31, 2017 | $7.73M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.56M | – |
| Q3 FY2016 | Sep 30, 2016 | $7.40M | – |
See a number that looks wrong?